Register Of All-Party Parliamentary Groups [as at 28 April 2016] Cancer
|
Title |
All-Party Parliamentary Group on Cancer |
|
Purpose |
To keep cancer on the political agenda, monitor implementation of government initiatives, provide briefings to parliamentarians and ensure policy making is evidence based and patient centred. |
|
Category |
Subject Group |
|
Officers |
||
|
Role |
Name |
Party |
|
Chair & Registered Contact |
Mr John Baron |
Conservative |
|
Vice Chair |
Nic Dakin |
Labour |
|
Vice Chair |
Grahame Morris |
Labour |
|
Vice Chair |
Guto Bebb |
Conservative |
|
Vice Chair |
David Tredinnick |
Conservative |
|
Vice Chair |
Albert Owen |
Labour |
|
Vice Chair |
Jo Churchill |
Conservative |
|
Vice Chair |
Baroness Masham of Ilton |
Crossbench |
|
Vice Chair |
Baroness Morgan of Drefelin |
Crossbench |
|
Vice Chair |
Baroness Finlay of Llandaff |
Crossbench |
|
Vice Chair |
Mark Durkan |
Social Democratic & Labour Party |
|
Contact Details |
|
Registered Contact: Mr John Baron MP, House of Commons, London, SW1A 0AA. Tel: 020 7219 8138. Email: baronj@parliament.uk.
Public Enquiry Point: Rebecca Leech, Macmillan Cancer Support, 89 Embankment, London SE1 7UQ. Tel: 020 7091 2013. Email: rleech@macmillian.org.uk
Secretariat: Macmillian Cancer Support acts as the group's secretariat. http://www.macmillan.org.uk/
Group's Website: http://www.macmillan.org.uk/GetInvolved/APPG/APPG.aspx
|
|
Annual General Meeting |
|
|
Date of most recent AGM in this Parliament |
16/06/2015 |
|
Did the group publish an income and expenditure statement relating to the AGM above? |
No |
|
Reporting year |
16 Jun to 15 Jun |
|
Next reporting deadline |
16/10/2016 |
|
Registrable benefits received by the group |
|||
|
Financial Benefits |
|||
|
Source |
Value £s |
Received |
Registered |
|
Pfizer LTD |
6,900 |
09/01/2015 |
07/07/2015 |
|
Eli Lilly |
2,800 |
06/10/2015 |
06/11/2015 |
|
Boehringer-Ingelheim |
2,800 |
15/10/2015 |
06/11/2015 |
|
Sanofi-Pasteur |
4,800 |
21/10/2015 |
06/11/2015 |
|
Bristol Myers Squibb |
6,900 |
08/01/2016 |
15/01/2016 |
|
Pfizer |
6,900 |
07/01/2016 |
15/01/2016 |
|
Roche |
6,900 |
13/01/2016 |
15/01/2016 |
|
Merck Serono |
6,900 |
26/11/2015 |
15/01/2016 |
|
Celgene |
4,800 |
22/12/2015 |
15/01/2016 |
|
Novartis Phamaceuticals UK Ltd |
6,900 |
07/03/2016 |
07/04/2016 |
|
Benefits In Kind |
||||
|
Source |
Description |
Value £s In bands of £1,500 |
Received |
Registered |
|
Macmillian Cancer Support |
Secretariat
From : 01/01/2015 To : 31/12/2015
|
51,001-52,500 |
01/01/2015 |
07/07/2015 |